AstraZeneca plc Global Capability Center (Chennai)

AstraZeneca's Global Technology & Operations Centre in Chennai is a growing GCC at the intersection of pharmaceutical science and advanced data technology, serving as one of AstraZeneca's primary hubs for data science, digital health, and commercial analytics capabilities. Established in 2011 and grown to over 4,500 professionals, the centre's work directly supports AstraZeneca's drug development pipelines and the commercialisation of blockbuster medicines including Tagrisso and Farxiga. Chennai-based data scientists and engineers are not peripheral to the pharmaceutical enterprise — they build the analytics and technology platforms that help AstraZeneca make decisions about clinical trial design, patient selection, regulatory submissions, and commercial performance.

The technology capabilities at AstraZeneca GTOC Chennai are evolving rapidly in response to the pharmaceutical industry's embrace of AI in drug discovery and development. Teams are building machine learning models for clinical biomarker identification, patient recruitment optimisation for clinical trials, and real-world evidence analytics that support regulatory submissions and market access decisions globally. An AI programme launched in 2023 focuses specifically on applying generative AI to scientific literature synthesis and molecular property prediction — areas where AI has the potential to fundamentally accelerate the early drug discovery process.

AstraZeneca India targets 5,500 employees by 2027, with growth concentrated in data science, ML engineering, and commercial analytics. The proximity to IIT Madras and Chennai's established biomedical research ecosystem provides a valuable talent pipeline for roles requiring both computational and life sciences expertise. AstraZeneca's partnership with IIT Madras for drug discovery AI research further deepens the centre's connection to India's scientific community. As the pharmaceutical industry increasingly uses AI as a drug discovery tool, the Chennai centre's capabilities position it as a meaningful contributor to AstraZeneca's global scientific agenda.

Parent Enterprise Overview